SANGINITA Latest Share Price (SANGINITA)
TODAY IN ONE LINE
With a market cap of ₹445.9 Cr., it trades at a P/E of N/A. Track live valuations, technical indicators, and peers comparison below. Check delivery conviction and recent filings to build your view.
How good is this company?
Overall performance across 5 key dimensions.
SANGINITA flags & news
Key strengths, potential risks, and recent updates.
Green Flags
- ●Strong Price MomentumRobust returns of 24.1% over 1Y
- ●High Promoter HoldingPromoters hold 68.0% skin-in-the-game
- ●Virtually Debt-FreeVery low Debt-to-Equity of 0.26x
- ●Promoter BuyingPromoters increased holdings by 42.60% QoQ
- ●Zero Pledge RiskNo recent active promoter pledging found
Red Flags
- ●Negative EarningsCompany is reporting negative EPS of ₹-1.90 (Loss Making)
Latest SANGINITA News
What changed recently?
Recent events, corporate actions, and announcements.
SANGINITA valuation: P/E, P/B and sector benchmarks.
Twelve years of multiples investors have paid for SANGINITA, framed against the sector median so the premium or discount is obvious at a glance.
Market-priced ratios use the latest available quote; accounting metrics use the latest reported filing. Compare values with matched peers and the company's own history.
Valuation
Profitability
Growth
Financial Health
SANGINITA technical analysis: indicators, pivots and CPR.
Latest RSI, MACD and moving-average signals plus the latest pivot and Central Pivot Range levels for SANGINITA — derived from the latest tape, not yesterday's close.
SANGINITA last traded at ₹15.02 with an intraday range of ₹15.01–₹15.45 — latest indicator, pivot and CPR signals below.
Pivot points
Standard pivot — most widely referenced.
Pivot levels · Classic
Last: ₹15.02| Level | Price (₹) | Distance | % Δ |
|---|---|---|---|
| R4 | 16.19 | +1.17 | +7.79% |
| R3 | 15.75 | +0.73 | +4.86% |
| R2 | 15.60 | +0.58 | +3.86% |
| R1 | 15.31 | +0.29 | +1.93% |
| PIVOT | 15.16 | 0.14 | 0.93% |
| CURRENT | 15.02 | — | — |
| S1 | 14.87 | -0.15 | -1.00% |
| S2 | 14.72 | -0.30 | -2.00% |
| S3 | 14.43 | -0.59 | -3.93% |
| S4 | 13.99 | -1.03 | -6.86% |
SANGINITA is trading Below CPR, indicating Bearishness
CPR is Wider, suggesting unlikely for trending moves
Day's range: ₹–₹
Trading Inside opening range
SANGINITA financials: P&L, balance sheet, cash flow, ratios.
Reported annual and quarterly results for SANGINITA — consolidated or standalone — with margins, YoY growth and key ratios inline.
SANGINITA reports its full P&L, balance sheet, cash flow and ratios on this page — current market capitalisation of ₹445.9 Cr. and reported EPS of ₹-1.90.
SANGINITA segment analysis : revenue and profit mix.
Disclosed business segments at SANGINITA with their share of revenue and profit, switchable between consolidated and standalone reporting.
SANGINITA discloses revenue and profit across multiple business segments — toggle between consolidated and standalone views to see the mix.
Segment-wise Financial Analysis
The Bull, Bear, and Flip case for SANGINITA.
Our AI distills the core fundamental drivers supporting SANGINITA, the risks that threaten it, and the quantitative conditions that could weaken the thesis.
SANGINITA's investment case rests on 9 positive markers and 10 flagged concerns drawn from the latest reported filings.
What you're getting.
Current price (10.20) is significantly below book value (21.58), indicating potential undervaluation.
Debt-to-equity ratio is low at 0.47, suggesting financial stability and low leverage.
Copper-based chemicals serve diverse industries like pharma, paints, and electroplating.
Capital expenditure grew 62.18% over five years, indicating investment in future.
Trailing twelve months revenue growth is 51.59%, suggesting recent sales recovery.
Key Risks.
Reported negative quarterly profit (-0.68 Cr) and -409.00% quarterly profit decline.
Quarterly sales decreased significantly by -28.10%, indicating revenue contraction.
Extremely low ROE (1.28%) and ROCE (4.19%) reflect inefficient capital utilization.
Very low OPM of 1.62% suggests operational inefficiencies and limited pricing power.
Promoter holding drastically decreased from 64.64% to 30.00%, signaling insider concern.
Flip Conditions.
Reassess if quarterly profit growth turns negative for two consecutive quarters. The bull case relies on compounding earnings.
Watch interest coverage if debt-to-equity climbs above 1.00. Balance sheet risk re-prices growth multiples fast.
SANGINITA peer comparison — same-sector benchmarks.
Same-sector listed peers ranked on P/E, market cap, dividend yield and growth — SANGINITA is highlighted for quick read-across.
Quick Compare
Peer Comparison
| Company Name |
|---|
SANGINITA chart patterns: breakouts, tops and bottoms.
Auto-detected classical chart patterns for SANGINITA — Double Top/Bottom, Head & Shoulders, Triple Bottom and more — with break levels, targets and quality scores across Intraday, Daily and Weekly timeframes.
SANGINITA delivery volume — last 20 sessions of conviction.
Daily traded volume and delivery percentage for SANGINITA over 20 sessions — the gap between intraday flipping and genuine accumulation.
Latest session delivery in SANGINITA stood at 84.7% of traded volume, against a 20-day average of 77.2%.
SANGINITA announcements: results, concalls, ratings, M&A.
Filings SANGINITA sent to the exchanges, sequenced as they hit the tape — concall transcripts, results, credit ratings and presentations.
SANGINITA files concall transcripts, results, credit ratings and corporate-action notices on the NSE and BSE exchange portals — latest 66 documents below.
Copy of Newspaper Publication
Sanginita Chemicals Limited has informed the Exchange about Copy of Newspaper Publication
Shareholders meeting
Sanginita Chemicals Limited has informed the Exchange regarding Notice of Extraordinary General Meeting to be held on October 07, 2026
Copy of Newspaper Publication
Sanginita Chemicals Limited has informed the Exchange about Copy of Newspaper Publication
Outcome of Board Meeting
Sanginita Chemicals Limited has informed the Exchange regarding Outcome of Board Meeting held on September 09, 2026.
General Updates
Sanginita Chemicals Limited has informed the Exchange about General Updates
SANGINITA dividend history, splits and bonus issues.
Every dividend, stock split and bonus issue SANGINITA has declared, sequenced by announce and record date.
SANGINITA corporate-action history below covers all declared dividends, stock splits and bonus issues recorded with NSE and BSE.
About SANGINITA: business, sector, key facts.
What SANGINITA does, where it operates, the people running it, and the numbers that describe the entity behind the ticker.
SANGINITA operates in the Specialty Chemicals industry under the Chemicals sector, listed as NSE: SANGINITA.
Sanginita Chemicals Limited is an Indian-based manufacturer and exporter of various copper-based chemicals. Their primary focus lies in the production and distribution of cuprous chloride, cupric chloride, and copper sulphate. These core products serve a wide range of industrial applications both domestically within India and across international markets.
The company's product portfolio extends beyond these core chemicals to include copper phthalocyanine blue crude. This further diversifies their offerings and strengthens their position within the chemical industry. The versatility of their products allows Sanginita to cater to a diverse customer base across several sectors.
Sanginita's chemicals find applications in a broad spectrum of industries. Their products are integral components in the manufacturing processes of dyes and pigments, paints, pharmaceuticals, and electroplating solutions. Furthermore, their copper compounds are utilized in metal extraction processes, ink and carbon paper production, and even in the specialized coating of PVC pipes.
Established in 2003 and headquartered in Gandhinagar, India, Sanginita Chemicals Limited has built a significant presence in the global chemical market. Their success is attributable to their focus on producing high-quality copper-based chemicals that meet the diverse needs of various industries. The company's continued operation and international reach indicate a strong market position and sustained growth in the sector.
Related
Peers, sector trends, screeners and strategy playbooks contextual to this stock.
- ADVANCE AGROLIFE (ADVANCE) Share PricePeer
- AGRO PHOS INDIA (AGROPHOS) Share PricePeer
- ARVEE LABORATORIES I (ARVEE) Share PricePeer
- BAYER CROPSCIENCE (BAYERCROP) Share PricePeer
- BEST AGROLIFE (BESTAGRO) Share PricePeer
- Top Gainers TodayScreener
- EMA Crossover ScreenerScreener
- Stock Quality ScorecardScreener
- Technical DashboardScreener
- Results CalendarScreener
- FII Buying ActivityScreener
- All Technical ScreenersScreener
- All Trading StrategiesStrategy
Questions investors ask about SANGINITA (SANGINITA).
Quick answers grounded in this page's data — price action, fundamentals, ratios and ownership.
01What is the current share price of SANGINITA (SANGINITA)?
The current share price of SANGINITA (SANGINITA) is ₹15.02. Today, the stock has gained by ₹0.47 (3.23%), trading in a range of ₹15.01 to ₹15.45. The stock opened at ₹15.30 with a trading volume of 2,53,374 shares.
02Is SANGINITA stock a good investment for long-term?
SANGINITA can be considered for long-term investment based on several factors. The company has a market capitalization of ₹445.9 Cr., P/E ratio of 0, ROE of -20.85%, and ROCE of -13.3%. The dividend yield stands at 0%. However, investment decisions should be based on your financial goals, risk appetite, and thorough research. It's recommended to consult with a SEBI-registered financial advisor before making investment decisions.
03What is the 52-week high and low price of SANGINITA stock?
The 52-week high price of SANGINITA (SANGINITA) is ₹15.87, while the 52-week low is ₹9.26. Currently trading at ₹15.02, the stock is 62.2% above its 52-week low and 5.36% below its 52-week high. These levels help investors understand the stock's price volatility and trading range over the past year.
04Should I buy SANGINITA stock at the current price?
Whether to buy SANGINITA stock at ₹15.02 depends on multiple factors. The stock is currently trading with a P/E ratio of 0 and P/B ratio of 3.16. Today's performance shows a gain of 3.23%. Consider analyzing the company's fundamentals, technical indicators, industry trends, and your investment horizon. Compare these metrics with industry peers and consult a financial advisor for personalized advice.
05What is the dividend yield of SANGINITA and when is the next dividend?
SANGINITA offers a dividend yield of 0%, which means for every ₹100 invested at the current price of ₹15.02, you can expect to receive approximately ₹0.00 annually as dividends. The face value of the stock is ₹4.00. For information about the next dividend announcement and ex-dividend date, please check the company's official announcements or visit the BSE/NSE websites.
06What are the key financial ratios and metrics of SANGINITA?
SANGINITA's key financial metrics include: P/E Ratio: 0, P/B Ratio: 3.16, ROE: -20.85%, ROCE: -13.3%, Dividend Yield: 0%, EPS: ₹-1.90, Book Value: ₹7.70, and Debt-to-Equity: 0.26. The company's market cap stands at ₹445.9 Cr.. These metrics help evaluate the company's valuation, profitability, and financial health.
07How is SANGINITA stock performing today in the market?
SANGINITA stock opened at ₹15.30 and is currently trading at ₹15.02, showing a gain of ₹0.47 (3.23%). The intraday high is ₹15.45 and low is ₹15.01. The trading volume stands at 2,53,374 shares, indicating moderate market participation today.
08What is the P/E ratio of SANGINITA and what does it indicate?
SANGINITA has a Price-to-Earnings (P/E) ratio of 0, which means investors are willing to pay 0.00 for every ₹1 of earnings. With an EPS of ₹-1.90, this P/E ratio suggests the stock may be undervalued or facing growth challenges. Compare this with industry peers and historical P/E ratios for better context.
The data, ratios and commentary about SANGINITA (SANGINITA) on this page are published for educational and informational purposes only and are not investment, legal or tax advice. StockeZee is not a SEBI-registered investment adviser, research analyst or portfolio manager, and no content here should be construed as a recommendation to buy, hold or sell any security. Live and historical market data may be delayed, revised by the exchanges, or contain errors; figures sourced from third-party feeds and corporate disclosures may not always be current. Past performance is not indicative of future results, and equity investments carry the risk of capital loss. Before acting on anything you read here, please consult a SEBI-registered financial advisor and read all scheme-related documents carefully.